Comment on the Article “The Effect of Pharmacological Thromboprophylaxis, Tourniquet and Drainage on Hemorrhagic Complications in the Early Stage after Knee Arthroplasty: Preliminary Results”

Cover Page


Cite item

Full Text

Abstract

.

About the authors

M. V. Belov

Solovyеv Clinical Hospital,
Yaroslavl State Medical University

Author for correspondence.
Email: micbelov@yandex.ru

Cand. Sci. (Med.), Head of Department of Arthroplasty; Associate professor, Department of Traumatology and Orthopedics

Yaroslavl

Россия

References

  1. Liu J., Zhao J., Yan Y., Su J. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(9):e14539. doi: 10.1097/MD.0000000000014539.
  2. Memtsoudis S.G., Pumberger M., Ma Y., Chiu Y.L., Fritsch G., Gerner P. et al. Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty. J Orthop Res. 2012;30(11):1811-1821. doi: 10.1002/jor.22139.
  3. Kinov P., Tanchev P.P., Ellis M., Volpin G. Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations. Int Orthop. 2014;38(1):169-175. doi: 10.1007/s00264-013-2134-8.
  4. Профилактика венозных тромбоэмболических осложнений в травматологии и ортопедии. Российские клинические рекомендации. Травматология и ортопедия России. 2012;1(приложение):2-24.
  5. Markovic-Denic L., Zivkovic K., Lesic A., Bumbasirevic V., Dubljanin-Raspopovic E., Bumbasirevic M. Risk factors and distribution of symptomatic venous chromboembolism in total hip and knee replacements: prospective study. Int Orthop. 2012;36(6):1299-1305. doi: 10.1007/s00264-011-1466-5.
  6. Falck-Ytter Y., Francis C.W., Johanson N.A., Curley C., Dahl O.E., Schulman S. [et al.] Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-e325S. doi: 10.1378/chest.11-2404.
  7. Anderson D.R., Dunbar M., Murnaghan J., Kahn S.R., Gross P., Forsythe M. et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018;378(8):699-707. doi: 10.1056/NEJ Moa1712746.
  8. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355(9212):1295-1302. doi: 10.1016/S0140-6736(00)02110-3.
  9. Anderson D.R., Dunbar M.J., Bohm E.R., Belzile E., Kahn S.R., Zukor D. et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med. 2013;158(11):800-806. doi: 10.7326/0003-4819-158-11-201306040-00004.
  10. Arsoy D., Giori N.J., Woolson S.T. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA. Clin Orthop Relat Res. 2018;476(2):381-387. doi: 10.1007/s11999.0000000000000041.
  11. Yhim H.Y., Lee J., Lee J.Y., Lee J.O., Bang S.M. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study. PLoS One. 2017;12(5):e0178214. doi: 10.1371/journal.pone.0178214.
  12. Alcelik I., Pollock R.D., Sukeik M., Bettany-Saltikov J., Armstrong P.M., Fismer P. A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty. 2012;27(3):331-340. doi: 10.1016/j.arth.2011.04.046.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies